Fulvestrant is used for the treatment of breast cancer in postmenopausal women. It blocks the action of estrogen receptors in the body, which lowers estrogen production and helps decrease the cancer's growth. On occasion, fulvestrant is used in an off-label fashion to treat breast cancer in premenopausal women. Fulvestrant has not been approved for treating breast cancer in children, adolescents, or men.
Fulvestrant (Faslodex®) is a prescription medication used to treat breast cancer in postmenopausal women. Specifically, the drug has been licensed to treat postmenopausal women with hormone receptor-positive breast cancer that has become worse while taking another breast cancer hormone treatment.
Understanding Breast Cancer
Women in the United States get breast cancer more than any other type of cancer, except for skin cancer. Each year, more than 211,000 American women learn that they have breast cancer. Most causes of breast cancer are not known. In 5 to 10 percent of these cases, there is a hereditary component. Common breast cancer symptoms include:
A lump or thickening in or near the breast or in the underarm area